Wir verwenden Cookies und Analyse-Tools, um die Nutzerfreundlichkeit der Internet-Seite zu verbessern und für Marketingzwecke. Wenn Sie fortfahren, diese Seite zu verwenden, nehmen wir an, dass Sie damit einverstanden sind. Zur Datenschutzerklärung.
The Use of Sustained Release Pharmaceutical Forms
Details
It seems necessary to have a certain and constant blood concentration of the drug during the treatment period in many diseases. The use of continuous release pharmaceutical forms can significantly help to solve these problems as well as the pharmaceutical form of slow-release oral pellets has special features such as the absence of pressing problems the use of several types of drugs or other side substances in a single dose without adverse effects. and physico-chemical on each other and strengthening the medicinal effect or reducing side effects as well as Multi-Ingredient Preparation compounds such as Dolo-Neurobin Merck which includes diclofenac sodium, vitamin B or Ger Combaren Ciba Cancer which includes diclofenac sodium and codeine phosphate hydrate or B-Voltaren, Ger, which includes diclofenac sodium, vitamin B derivatives or combining diclofenac sodium with misoprostol in the case of patients who are at risk of developing peptic ulcer caused by NSAIDs.
Autorentext
Dr. Mehrara Akanchi : PharmD, Pharmacist, Islamic Azad University of Medical Sciences, Tehran Branch, Tehran, Iran.Dr. Bita Fazeli : General Practitioner Iran University of Medical Science, Tehran, Iran.
Weitere Informationen
- Allgemeine Informationen
- GTIN 09786204722719
- Sprache Englisch
- Größe H220mm x B150mm x T8mm
- Jahr 2022
- EAN 9786204722719
- Format Kartonierter Einband
- ISBN 6204722719
- Veröffentlichung 06.11.2022
- Titel The Use of Sustained Release Pharmaceutical Forms
- Autor Mehrara Akanchi
- Untertitel to Gain Patient Satisfaction
- Gewicht 197g
- Herausgeber Noor Publishing
- Anzahl Seiten 120
- Genre Medical Books